Promotion of Research and Innovation in Pharma-MedTech: Industry dialogue

Industry stakeholders were encouraged to submit their feedback and project details through the Expression of Interest (EoI) hosted on the Department of Pharmaceuticals website, which will be open till April 7, 2025. This process will help refine the implementation strategy of the PRIP Scheme, ensuring it aligns with industry need and drives sectoral growth.

SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2025

SEBI has provided that unpublished price sensitive information, not emanating from within the organisation, shall be entered into structured digital database not later than 2 calendar days from the receipt of such information. It is clarified that for unpublished price sensitive information not emanating from within the Listed Company, trading window may not be closed.